C. AndrewSchroederMDFCCP

Pulmonology • Beverly Hills, CA

C. Andrew Schroeder, M.D., Inc.

Join to view full profile

Dr. Schroeder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schroeder's full profile

Already have an account?

Office
9454 Wilshire Blvd
510
Beverly Hills, CA 90212
Phone+1 310-734-4594

Summary

C. Andrew Schroeder provides high-quality, personalized healthcare services. In 2006, he opened his practice in Beverly Hills, which provides pulmonary care on a referral basis. He also provides comprehensive primary and concierge care on a retainer basis to a limited number of individuals. This includes exceptional preventative care, clinical genomic medicine, detailed health assessment, priority access to leading specialists, and care coordination.

Dr. Schroeder is the past Clinical Chief of Pulmonary and Critical Care Medicine at Cedars-Sinai Medical Center and is a Clinical Instructor of Medicine at the UCLA David Geffen School of Medicine. He has been chosen by Los Angeles Magazine as one of the best doctors in Los Angeles for several years. Dr. Schroeder is also a primary investigator on clinical trials aimed at better treating lung disease.

Education & Training

Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2000 - 2002
Cedars-Sinai Medical CenterInternship, 1999 - 2000
New York Medical CollegeClass of 1999
New York Medical CollegeMSc, 1993 - 1996
University of California, Los AngelesB.A., 1987 - 1992

Certifications & Licensure

CA State Medical License 2001 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Super Doctor Super Doctor

Clinical Trials

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Start of enrollment: 2021 Jan 26
Recruiting
Phase 3
Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History Start of enrollment: 2014 Jun 13
Completed
Phase 3
Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist Start of enrollment: 2013 Aug 01
Completed
Phase 3
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD Start of enrollment: 2024 Jan 11
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

851 citations
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomi...
J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta
Lancet. 2016-10-29
153 citations
Benralizumab for the Prevention of COPD Exacerbations
Gerard J. Criner, Bartolome R. Celli, Christopher E. Brightling, Alvar Agusti, Alberto Papi
The New England Journal of Medicine. 2019-05-20
10 citations
Airflow limitation and breathing strategy in congestive heart failure patients during exercise.
C. Andrew Schroeder, David Balfe, Steven S. Khan, Zab Mohsenifar
Respiration; International Review of Thoracic Diseases. 2003-03-01

Journal Articles

Benralizumab for the Prevention of COPD Exacerbations.
GALATHEA Study Investigators, New England Journal of Medicine, 9/2019
Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a ran...
CALIMA study investigators, Lancet, 10/2016
Airflow limitation and breathing strategy in congestive heart failure patients during exercise
C.A. Schroeder, D. Balfe, S. Khan, Z. Mohsenifar, Respiration, 1/1/2003
Inhibition of NO synthesis or endothelium removal reveals a direct vasoconstrictor effect of insulin on isolated arterioles
C.A. Schroeder, Jr., Y.L. Chen, E.J. Messina, American Journal of Physiology, 1/1/1999
Preconditioning with Ischemia or Adenosine Protects Skeletal Muscle from Ischemic Tissue Reperfusion Injury
C.A. Schroeder, Jr., H.T. Lee, P.M. Shah, S.C. Babu, C.I. Thompson, F.L. Belloni, Journal of Surgical Research, 1/1/1996
Join now to see all

Books/Book Chapters

Critical Care On Call.
Chapter: Altered Mental Status.
Page 24 - 27C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Brain Death.
Page 46 - 47C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Death.
Page 76 - 78C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Rhinorrhea/Otorrhea.
Page 189 - 191C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Pacemaker Malfunction.
Page 196 - 198C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Polyuria.
Page 213 - 215C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Seizures.
Page 233 - 235C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Pregnancy.
Page 217 - 220C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Critical Care On Call.
Chapter: Tachycardias.
Page 244 - 248C.A. SchroederEditors: Lefor, Bogdonoff, Geehan, Maldonado.Lange Medical Books / McGraw Hill, New York, NY2002
Join now to see all

Abstracts/Posters

Tobacco smoke extract (TSE)-mediated regulation of cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptor-gamma (PPAR gamma) in human bronchial epithe...
C.A. Schroeder, S. Sharma, M. Qin, S.M. Dubinett, R. Batra, American Thoracic Society, 100th International Conference, 1/1/2004
Airflow limitation in patients with congestive heart failure during exercise.
C.A. Schroeder, D. Balfe, S. Kahn, Z. Mohsenifar, Am J Resp Crit Care, 1/1/2001
Effects of Insulin on Isolated Arterioles from Red and White Rat Gastrocnemius Muscles.
C.A. Schroeder, Jr., Y.L. Chen, E.J. Messina, J FASEB, 1/1/1997
Mechanisms of arteriolar dilation to PGI2 and PGE2.
P.A. Pino, F.S. Ciminello, C.A. Schroeder, Jr., Y.L. Chen, and E.J. Messina, J FASEB, 1/1/1997
Role of Prostaglandins in Activation of ATP-Sensitive Potassium Channels in Isolated Skeletal Muscle Arterioles.
F.S. Ciminello, C.A. Schroeder, Jr., Y.L. Chen, C.I. Thompson, F.L. Belloni, E.J. Messina, J FASEB, 1/1/1996
Endothelium-Derived PGI2 Contributes to Hypoxia Induced Dilation of Isolated Skeletal Muscle Arterioles by Activation of ATP-Sensitive Potassium Channels.
C.A. Schroeder, Jr., F.S. Ciminello, Y.L. Chen, C.I. Thompson, F.L. Belloni, E.J. Messina, J FASEB, 1/1/1996
Differential Glibenclamide Sensitivity of Isolated Rat Thoracic Aorta to Adenosine Receptor Agonists.
F.L. Belloni, C.I. Thompson, K. Fratta, J.L.S. Lewy, C.A. Schroeder, Jr., H. Machen, Drug Development Research, 1/1/1994
Join now to see all

Other Languages

Spanish

Industry Relationships

Investigator, MACRO TrialsMacro is at the center of your next clinical trial. We work with sponsors and CROs to execute clinical trials for high-value therapeutics. We create access for diverse candidates and partner with leading clinicians looking to stay on the forefront of care.Disclosure: None2021 - Present